{ "cik": 1756262, "cik_padded": "0001756262", "entityName": "TransMedics Group, Inc.", "fiscal_years": [ { "accn": "0001193125-26-067032", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 59251000.0, "cost_of_revenue": 242688000.0, "eps_diluted": 4.87, "free_cash_flow": 133589000.0, "gross_profit": 362806000.0, "net_income": 190291000.0, "operating_cash_flow": 192840000.0, "operating_income": 108583000.0, "revenue": 605494000.0, "stockholders_equity": 473100000.0, "total_assets": 1068373000.0, "total_liabilities": 595273000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5991900828084176, "leverage": 1.2582392728809977, "net_margin": 0.3142739647296257, "operating_margin": 0.1793296052479463, "revenue_growth_yoy": 0.37132309643520406, "roa_avg2y": 0.20325359996453843, "roa_period_end": 0.178112887540213, "roe_avg2y": 0.5423690649747828, "roe_period_end": 0.40222151764954556 } }, { "accn": "0001193125-26-067032", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 129744000.0, "cost_of_revenue": 179459000.0, "eps_diluted": 1.01, "free_cash_flow": -80941000.0, "gross_profit": 262081000.0, "net_income": 35464000.0, "operating_cash_flow": 48803000.0, "operating_income": 37496000.0, "revenue": 441540000.0, "stockholders_equity": 228603000.0, "total_assets": 804076000.0, "total_liabilities": 575473000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5935611722607238, "leverage": 2.517346666491691, "net_margin": 0.08031888390632785, "operating_margin": 0.08492095846355935, "revenue_growth_yoy": 0.827392259842813, "roa_avg2y": 0.0469683595309786, "roa_period_end": 0.04410528358015909, "roe_avg2y": 0.19389565478875356, "roe_period_end": 0.1551335721753433 } }, { "accn": "0001193125-26-067032", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 151847000.0, "cost_of_revenue": 87530000.0, "eps_diluted": -0.77, "free_cash_flow": -164875000.0, "gross_profit": 154093000.0, "net_income": -25028000.0, "operating_cash_flow": -13028000.0, "operating_income": -28727000.0, "revenue": 241623000.0, "stockholders_equity": 137202000.0, "total_assets": 706047000.0, "total_liabilities": 568845000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6377414401774666, "leverage": 4.146040145187388, "net_margin": -0.10358285428125633, "operating_margin": -0.11889182735087306, "revenue_growth_yoy": 1.5853368856931918, "roa_avg2y": -0.0509116206974412, "roa_period_end": -0.035448065072155255, "roe_avg2y": -0.1542191837376031, "roe_period_end": -0.1824171659305258 } }, { "accn": "0001193125-26-067032", "filed": "2026-02-24", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11907000.0, "cost_of_revenue": 28187000.0, "eps_diluted": -1.23, "free_cash_flow": -57724000.0, "gross_profit": 65272000.0, "net_income": -36231000.0, "operating_cash_flow": -45817000.0, "operating_income": -31437000.0, "revenue": 93459000.0, "stockholders_equity": 187375000.0, "total_assets": 277147000.0, "total_liabilities": 89772000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.698402508051659, "leverage": 0.47910340226817877, "net_margin": -0.3876673193592912, "operating_margin": -0.33637209899528137, "revenue_growth_yoy": 2.08832859692023, "roa_avg2y": -0.17586156683817106, "roa_period_end": -0.1307284581828416, "roe_avg2y": -0.28390974379870626, "roe_period_end": -0.19336090727151434 } }, { "accn": "0000950170-25-029104", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3519000.0, "cost_of_revenue": 9103000.0, "eps_diluted": -1.6, "free_cash_flow": -32383000.0, "gross_profit": 21159000.0, "net_income": -44215000.0, "operating_cash_flow": -28864000.0, "operating_income": -39428000.0, "revenue": 30262000.0, "stockholders_equity": 67854000.0, "total_assets": 134893000.0, "total_liabilities": 67039000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6991937082810125, "leverage": 0.9879889173814366, "net_margin": -1.4610732932390456, "operating_margin": -1.302888110501619, "revenue_growth_yoy": 0.18031124458832248, "roa_avg2y": -0.30820545171285274, "roa_period_end": -0.3277783131815587, "roe_avg2y": -0.5148912632099916, "roe_period_end": -0.6516196539629204 } }, { "accn": "0001564590-22-008045", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 455000.0, "cost_of_revenue": 9004000.0, "eps_diluted": -1.16, "free_cash_flow": -30720000.0, "gross_profit": 16635000.0, "net_income": -28748000.0, "operating_cash_flow": -30265000.0, "operating_income": -26384000.0, "revenue": 25639000.0, "stockholders_equity": 103891000.0, "total_assets": 152026000.0, "total_liabilities": 48135000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6488162564842622, "leverage": 0.46332213569991626, "net_margin": -1.1212605795857873, "operating_margin": -1.0290572955263466, "revenue_growth_yoy": 0.08621420098288425, "roa_avg2y": -0.22343728747692607, "roa_period_end": -0.18909923302592976, "roe_avg2y": -0.3626592658004289, "roe_period_end": -0.2767130935307197 } }, { "accn": "0001564590-21-012527", "filed": "2023-02-27", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 165000.0, "cost_of_revenue": 9741000.0, "free_cash_flow": -32451000.0, "gross_profit": 13863000.0, "net_income": -33547000.0, "operating_cash_flow": -32286000.0, "operating_income": -29603000.0, "revenue": 23604000.0, "stockholders_equity": 54649000.0, "total_assets": 105299000.0, "total_liabilities": 50650000.0 }, "period_end": "2019-12-28", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5873157092018302, "leverage": 0.9268239126059031, "net_margin": -1.4212421623453653, "operating_margin": -1.2541518386714117, "revenue_growth_yoy": 0.8133210417146808, "roa_avg2y": -0.4550103081597222, "roa_period_end": -0.3185880207789248, "roe_avg2y": 0.48762655076929784, "roe_period_end": -0.6138630167066186 } }, { "accn": "0001564590-21-012527", "filed": "2021-03-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 418000.0, "cost_of_revenue": 7283000.0, "free_cash_flow": -26402000.0, "gross_profit": 5734000.0, "net_income": -23756000.0, "operating_cash_flow": -25984000.0, "operating_income": -20237000.0, "revenue": 13017000.0, "stockholders_equity": -192242000.0, "total_assets": 42157000.0, "total_liabilities": 47880000.0 }, "period_end": "2018-12-29", "ratio_units": { "gross_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.44050088346009064, "roa_period_end": -0.5635125839125175, "roe_avg2y": 0.1316245851409828 } }, { "accn": "0001564590-20-011409", "filed": "2020-03-17", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -168724000.0 }, "period_end": "2017-12-30", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-067032", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3845", "sic_description": "Electromedical & Electrotherapeutic Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001756262.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001756262.json" }, "ticker": "TMDX" }